Description

Report Code: PHP11677. April, 2011. Montreal, QC

ARTICLE I

Global Opportunities for Canadian Life Sciences

Krista Robinson
Senior Manager, Tax Services
Ernst & Young LLP

Elizabeth Pringle, M.Sc.
Senior Manger, SR&ED Tax Credit Practice
Ernst &Young LLP

ARTICLE II

Quality Speed Access

Karen Arts, BSN, RN, CCRC
Director, Business Development
Ontario Institute for Cancer Research
Chair, Network of Networks

ARTICLE III

Considerations for Successful Outsourcing Partnerships

Joanne E. Watson, MSc
President and Chief Executive Officer
Integrated Research Inc.

ARTICLE IV

Quality Management Approach to Better Research

Marianne Vanderwel
Director, Human Research Protection Program
Institutional Review Board Services

ARTICLE V

Laying the Bedrock of the Clinical Trial Framework – Negotiation and Early Stage Best Practices

Tracey Allin, BScN, RN
Regional Research Manager, Clinical Operations
Eli Lilly Canada, Inc.

ARTICLE VI

Laying the Bedrock of the Clinical Trial Framework

Olga Farman
Associate
Lavery de Billy LLP

ARTICLE VII

Laying the Bedrock of the Clinical Trial Framework

Michelle Moldofsky, LLB, LLM
Policy and Legal Adviser, Office of Research Administration
St. Michael’s Hospital

ARTICLE VIII

The Patient Perspective and Patient Interests in Clinical Trials – Aligning Best Interests

Nadine Prévost
Director, Client Services and Social Action (Quebec Division)
Multiple Sclerosis Society of Canada

Hana Salaheddine
Multiple Sclerosis Patient Representative
Multiple Sclerosis Society of Canada

ARTICLE IX

Clinical Research: The Doctor and her Patient

Pierre Geoffroy, MD, CM, MSc, FCFP
Chief Medical Officer
Lambda Canada

ARTICLE X

Budget Negotiations and Budget Templates – Getting Down to Brass Tacks

Jean Langlais, Ph.D.
Director, Office of Research Agreements
Centre hospitalier universitaire Sainte-Justine

ARTICLE XI

Using Information Technology to Facilitate Successful Clinical Trials and Manage Privacy

Darran Boyer, MAcc
President
Independent Data Integrator

ARTICLE XII

Using Information Technology to Facilitate Successful Clinical Trials and Manage Privacy

Rady Khuong
Partner
Stein Monast LLP

ARTICLE XIII

Maximizing International Opportunities in Clinical Trials – A Global Review of Clinical Site Selection

Fabio A. Thiers, MD, MSc, PhD
CEO – ViS Research Institute
Director, Global Clinical Trials Research Program
Massachusetts Institute of Technology and National Bureau of Economic Research (NBER)

ARTICLE XIV

RESPONDENT Clinical Research : The Doctor and her Patient

Pierre Geoffroy, MD, CM, MSc, FCFP
Chief Medical Officer
Lambda Canada

ARTICLE XV

Using the Web to Facilitate Patient Participation in Clinical Trials

Sandra Gazel, MSc
Associate Director, Clinical Operations
Abbott Laboratories Canada

Sima Chiva-Razavi
Clinical Research Interim
Abbott Laboratories Canada

ARTICLE XVI

Legal, Ethical and Regulatory Compliance – Getting to Good (and Knowing When It is Good Enough)

Franca Cantini, MScN
Chief, Research Ethics Office
Jewish General Hospital

Felicia Tiseo
Research Ethics Quality Assurance Coordinator
Jewish General Hospital

Marie-Luce Fortier, LL.L, LL.B
Senior Manager, Development of Contractual Research
Centre Hospitalier de l’Université de Montréal (CHUM)

ARTICLE XVII

Canada Inspectorate: Protection of Participants, Quality of Processes..and Competitiveness?

Pierre Gervais, B.Pharm., L.Pharm., MSc
President, Executive Director
Q&T Research Sherbrooke Inc.

ARTICLE XVIII

Investigator-initiated Clinical Research: A Network to Discover Biomarkers through Biopsy-driven Clinical Research

Dr. Gerald Batist
Director of Segal Cancer Centre
Jewish General Hospital

ARTICLE XIX

Investigator Initiated Trials – Untangling that Tangled Web

P. Bradley Limpert
Partner, Patent and Trade Mark Agent
Cameron Mackendrick LLP

ARTICLE XX

Mastering IP and Related Legal Issues Through Effective Clinical Trial Agreements

Andrew Loh
Partner
Borden Ladner Gervais LLP

Beverley Moore
Associate
Borden Ladner Gervais LLP